PRESS-RELEASE ·Filed Jul 7, 2026

WST

West Pharmaceutical Services, Inc.
NEUTRAL
Impact 1/10
Horizonweeks Processed2mo ago WireGlobeNewswire
Press release: earnings
Actionable Insight • Neutral

This filing has no trading relevance. The only actionable takeaway is to expect Q2 2026 earnings on July 23, 2026. Monitor for the actual earnings release on that date for financial results and guidance updates.

DirectionNeutral
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d
WST ▲ +4.12% at T+60d
NEUTRAL call ✓ call won +4.12% · α vs SPY +2.13% · entry $356.08 → $370.76
Entry anchored
Jul 6, 03:59 PM ET
via exchange tick
T+1d
-0.67%
call -0.67% · α -0.37%
$353.68
settled 3mo ago
T+5d
+0.44%
call +0.44% · α -0.11%
$357.65
settled 3mo ago
T+20d
-2.29%
call -2.29% · α -3.62%
$347.94
settled 8w ago
T+60d
+4.12%
call +4.12% · α +2.13%
$370.76
settled 2d ago

Price Chart

Loading chart...

Executive Summary

This PRESS-RELEASE filing from West Pharmaceutical Services, Inc. (WST) announces the upcoming second-quarter 2026 earnings release date (July 23, 2026) and conference call details. The filing contains no financial results, guidance, or material business updates — it is purely a scheduling announcement.

Key Facts

  • Q2 2026 earnings results will be released before market open on July 23, 2026
  • Conference call to follow at 8:00 a.m. Eastern Time on the same day
  • Slide presentation will be available on the day of the call in the Investors section of the company's website
  • Webcast replay will be available for approximately 90 days after the event
  • Company operates over 50 sites with 26 manufacturing facilities worldwide
  • Over 10,000 team members and delivers over 41 billion components and devices annually
  • Fiscal year 2025 net sales were $3.07 billion

Financial Impact

No financial impact — this is a scheduling and logistics announcement only.

Risk Factors

  • No risk identified — this is a routine scheduling announcement

Market Snapshot

Exchange
NYSE
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
82% bullish (22 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-prn-302818743
12 reports for WST
Performance horizon
50% Hit rate 2 of 4 directional calls best @ T+60▲ +16.33%Apr 23, 2026
Filters
Rows
Reports for WST — sortable, filterable
TypeNow
Jul 23, 2026
10w ago
8-K
BULLISH ★ 7/10
$355.48 $353.77▼ −0.48%▼ −3.79%$364.89 (+2.65%)
Jul 23, 2026
10w ago
Press Release
BULLISH ★ 7/10
$355.48 $353.77▼ −0.48%▼ −3.79%$364.89 (+2.65%)
Jul 7, 2026
12w ago
Press Release
NEUTRAL ★ 1/10
$356.08 $347.94▼ −2.29%▼ −3.62%$364.89 (+2.47%)
May 11, 2026
20w ago
8-K
BEARISH ★ 7/10
$311.82 $330.92▼ −6.12%▼ −7.85%$364.89 (−17.02%)
Apr 27, 2026
22w ago
Insider Cluster
NEUTRAL ★ 2/10
$300.93 $316.17▲ +5.06%▲ +0.11%$364.89 (+21.25%)
Apr 27, 2026
22w ago
Insider Cluster
NEUTRAL ★ 2/10
$300.93 $316.17▲ +5.06%▲ +0.11%$364.89 (+21.25%)
Apr 27, 2026
22w ago
Insider Cluster
NEUTRAL ★ 2/10
$300.93 $316.17▲ +5.06%▲ +0.11%$364.89 (+21.25%)
Apr 27, 2026
22w ago
Insider Cluster
NEUTRAL ★ 2/10
$300.93 $316.17▲ +5.06%▲ +0.11%$364.89 (+21.25%)
Apr 27, 2026
22w ago
Insider Cluster
NEUTRAL ★ 2/10
$300.93 $316.17▲ +5.06%▲ +0.11%$364.89 (+21.25%)
Apr 27, 2026
22w ago
Insider Cluster
NEUTRAL ★ 2/10
$300.93 $316.17▲ +5.06%▲ +0.11%$364.89 (+21.25%)
Showing 10 of 12

US Market Status

Market Closed — Opens Mon (65h 28m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Jul 7, 2026